DiNAQOR is a genetic medicine platform company pioneering early-stage drug development and manufacturing to advance promising gene therapies to the clinic. Our patent-protected, industry leading platform is designed to overcome the challenges and limitations of advanced gene therapy development by using proprietary engineered heart tissue technology (EHT), a novel Loco-Regional Perfusion system (LRP) and a fully integrated manufacturing solution. Our company is headquartered in the Greater Zurich Area, Switzerland, with additional presence in Laguna Hills, California and Hamburg, Germany.
Company Details
- Employees
- 10
- Founded
- 2019
- Address
- Wagistrasse 25, Schlieren,zurich 8952,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dinaqor.com
- HQ
- Schlieren, Zurich
Dinaqor Questions
Dinaqor's website is dinaqor.com
Dinaqor's LinkedIn profile is https://www.linkedin.com/company/dinaqor
Dinaqor has
10 employees.
View email and phone details for 10
employees at Dinaqor.
Dinaqor's industry is
Biotechnology Research
Dinaqor's top competitors are
Cdr-Life Inc.,
Dinabios,
Immunos Therapeutics Ag,
Siegfried,
Dinamiqs,
Cutiss Ag,
Evitria Ag,
Molecular Partners,
Memo Therapeutics Ag,
Vesalic Limited.
Dinaqor's categories are Biotechnology Research
Dinaqor's founding year is 2019
